Cannabis
Agential Cannabis 2026 Set to Spotlight Southeast Asia
Agential Cannabis 2026, Asia-Pacific’s premier medical cannabis trade fair and conference, will be held on September 23–24 at Bangkok’s BITEC. Bringing together industry leaders, regulators, and scientists, it features a high-level conference, global trade exhibition, and operator-focused program covering markets, production, AI, regulation, and therapeutics. Early registration is recommended due to limited booth space.
In September 2026, the global medical cannabis industry will turn its focus to Southeast Asia. Agential Cannabis 2026, the premier trade fair and conference for medical cannabis in the Asia-Pacific region, is scheduled to take place from September 23rd to 24th, 2026, at the Bangkok International Trade and Exhibition Centre (BITEC).
The event will bring together senior representatives from industry, regulatory bodies, and the scientific community, offering an international platform to exchange insights on market trends, regulatory developments, and technological innovations shaping the future of medical cannabis in Asia and worldwide.
Agential Cannabis: Leading Conference and Trade Fair for Medical Cannabis
The conference program of the Agential Cannabis 2026 feature a high-caliber lineup of executives, regulators, and industry experts spanning the entire value chain. Alongside this, a global trade exhibition will highlight solutions, technologies, and collaborative opportunities from the Asia-Pacific region, Europe, and other international markets.
Particular emphasis will be placed on an operator-oriented program, designed to address the real needs of the market. Key topics include market and investment strategies, production and genetics, artificial intelligence and technology applications, regulatory updates, and therapeutic uses.
Industry-Driven Format and Opportunities
Building on the success of AGENTIAL AI AgBio 2025, Agential Cannabis 2026 was developed “by industry for industry.” The event seeks to move beyond traditional trade fair formats, creating space for strategic dialogue, global insights, and sustainable business relationships. Exhibitors and sponsors will have the opportunity to showcase their offerings and engage with key stakeholders from across the sector.
Due to limited booth availability, early registration for teh Agential Cannabis 2026 event is strongly recommended. Additional information on speakers, program highlights, and registration details will be published shortly, ensuring attendees and participants can plan their engagement and maximize the benefits of this leading international platform.
Agential Cannabis 2026 promises to be a pivotal event for anyone involved in the medical cannabis industry, combining expert-led conferences with an international trade exhibition to foster knowledge sharing, innovation, and growth opportunities.
__
(Featured image by Andreas Brucker via Unsplash)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in HanfJournal. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Markets1 week agoSugar Markets Cautious Amid Surplus Outlook and Steady Demand
-
Crypto3 days agoEthereum Momentum Builds as Bitcoin Rallies and Trilemma Claims Emerge
-
Fintech3 hours agoFintech Monet Accelerates Its Growth Strategy Toward 2026
-
Crowdfunding1 week agoCrowdfunding Grants Open for Business Projects Until January 2026



